XML 24 R11.htm IDEA: XBRL DOCUMENT v3.22.0.1
FINANCIAL INSTRUMENTS
12 Months Ended
Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTS
The following tables show the Company’s cash, cash equivalents and available-for-sale securities by significant investment category as of December 31, 2021 and 2020, respectively:
December 31, 2021
Amortized CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Aggregate Fair
Value
Cash and Cash Equivalents
Short-term
Marketable Securities (1)
Long-term
Marketable Securities (2)
Level 1:
Cash
$301,177 $— $— $301,177 $301,177 $— $— 
Level 2:
Money market instruments
285,099 — — 285,099 285,099 — — 
Corporate debt securities
584,000 386 (2,086)582,300 — 200,304 381,996 
U.S. government agency securities
224,774 182 (325)224,631 — 146,421 78,210 
Commercial paper68,384 — — 68,384 1,000 67,384 — 
Asset-backed securities56,936 10 (95)56,851 — 9,451 47,400 
Foreign and other
3,097 141 (12)3,226 — 3,039 187 
Subtotal
1,222,290 719 (2,518)1,220,491 286,099 426,599 507,793 
Total
$1,523,467 $719 $(2,518)$1,521,668 $587,276 $426,599 $507,793 

December 31, 2020
Amortized CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Aggregate Fair
Value
Cash and Cash Equivalents
Short-term
Marketable Securities (1)
Long-term
Marketable Securities (2)
Level 1:
Cash
$370,325 $— $— $370,325 $370,325 $— $— 
Level 2:
Money market instruments
264,833 — — 264,833 264,833 — — 
Corporate debt securities
413,137 3,261 (8)416,390 — 220,551 195,839 
U.S. government agency securities
265,298 1,555 (1)266,852 14,000 192,488 60,364 
Asset-backed securities31,659 85 (2)31,742 — 3,189 28,553 
Foreign and other
549 168 — 717 — — 717 
Subtotal
975,476 5,069 (11)980,534 278,833 416,228 285,473 
Total
$1,345,801 $5,069 $(11)$1,350,859 $649,158 $416,228 $285,473 
(1)The Company’s short-term marketable securities mature in one year or less.
(2)The Company’s long-term marketable securities mature between one and five years.
As of December 31, 2021, the Company had the ability and intent to hold all investments that were in an unrealized loss position until maturity. The Company considered its intent and ability to hold the securities until recovery of amortized cost basis, the extent to which fair value is less than amortized cost basis, conditions specifically related to the security’s industry and geography, payment structure and history and changes to the ratings (if any) in determining that the decline in fair value compared to carrying value is not related to a credit loss.
The Company has certain investments in non-marketable equity securities, measured using unobservable valuation inputs and remeasured on a nonrecurring basis, which are collectively considered strategic investments. As of December 31, 2021 and
2020, the fair value of the Company’s strategic investments was $16.5 million and $10.5 million, respectively. These investments were recorded in Other Assets in the Company’s Consolidated Balance Sheets.
See Note 1 to these Consolidated Financial Statements for additional discussion regarding the Company’s fair value measurements.